HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Study of avidity of antigen-specific antibody as a means of understanding development of long-term immunological memory after Vibrio cholerae O1 infection.

Abstract
The avidity of antibodies to specific antigens and the relationship of avidity to memory B cell responses to these antigens have not been studied in patients with cholera or those receiving oral cholera vaccines. We measured the avidity of antibodies to cholera toxin B subunit (CTB) and Vibrio cholerae O1 lipopolysaccharide (LPS) in Bangladeshi adult cholera patients (n = 30), as well as vaccinees (n = 30) after administration of two doses of a killed oral cholera vaccine. We assessed antibody and memory B cell responses at the acute stage in patients or prior to vaccination in vaccinees and then in follow-up over a year. Both patients and vaccinees mounted CTB-specific IgG and IgA antibodies of high avidity. Patients showed longer persistence of these antibodies than vaccinees, with persistence lasting in patients up to day 270 to 360. The avidity of LPS-specific IgG and IgA antibodies in patients remained elevated up to 180 days of follow-up. Vaccinees mounted highly avid LPS-specific antibodies at day 17 (3 days after the second dose of vaccine), but the avidity waned rapidly to baseline by 30 days. We examined the correlation between antigen-specific memory B cell responses and avidity indices for both antigens. We found that numbers of CTB- and LPS-specific memory B cells significantly correlated with the avidity indices of the corresponding antibodies (P < 0.05; Spearman's ρ = 0.28 to 0.45). These findings suggest that antibody avidity after infection and immunization is a good correlate of the development and maintenance of memory B cell responses to Vibrio cholerae O1 antigens.
AuthorsMohammad Murshid Alam, Mohammad Arifuzzaman, Shaikh Meshbahuddin Ahmad, M Ismail Hosen, Mohammad Arif Rahman, Rasheduzzaman Rashu, Alaullah Sheikh, Edward T Ryan, Stephen B Calderwood, Firdausi Qadri
JournalClinical and vaccine immunology : CVI (Clin Vaccine Immunol) Vol. 20 Issue 1 Pg. 17-23 (Jan 2013) ISSN: 1556-679X [Electronic] United States
PMID23114701 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Bacterial
  • Antigens, Bacterial
  • Cholera Vaccines
  • Lipopolysaccharides
  • Cholera Toxin
Topics
  • Adolescent
  • Adult
  • Antibodies, Bacterial (immunology)
  • Antibody Affinity
  • Antigens, Bacterial (immunology)
  • B-Lymphocytes (immunology)
  • Bangladesh
  • Cholera (immunology)
  • Cholera Toxin (immunology)
  • Cholera Vaccines (administration & dosage, immunology)
  • Female
  • Follow-Up Studies
  • Humans
  • Immunologic Memory
  • Lipopolysaccharides (immunology)
  • Male
  • Middle Aged
  • Vibrio cholerae O1 (immunology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: